| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $4.1M | — | -10.4% |
| Cost of Revenue | $3.7M | — | -16.7% |
| Gross Profit | $394K | — | +214.9% |
| R&D Expense | $276K | — | +20.0% |
| SG&A Expense | $1.4M | — | +3.8% |
| Operating Income | -$2.3M | — | -4.2% |
| Pre-tax Income | -$2.7M | — | -15.6% |
| Income Tax | -$377 | — | -11.2% |
| Net Income | -$2.7M | — | -15.3% |
| EPS (Basic) | -$0.28 | — | -12.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $2.7M | -46.1% | — |
| Accounts Receivable | $3.7M | +6.8% | +6.5% |
| Inventory | $6.5M | -0.0% | +13.4% |
| Current Assets | $14.1M | -11.4% | -32.4% |
| Total Assets | $24.9M | -8.5% | -23.4% |
| Current Liabilities | $5.7M | +19.9% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$1.9M | — | -49.7% |
| Capital Expenditures | $270K | — | +65.0% |
| Investing Cash Flow | -$270K | — | -143.3% |
| Financing Cash Flow | -$309K | — | -131.2% |
| Free Cash Flow | -$2.2M | — | -51.4% |
| +2.8% |
| Total Liabilities | $17.4M | +2.9% | -0.6% |
| Stockholders' Equity | $7.6M | -26.9% | -49.4% |